A case of primary lung cancer lesion demonstrated by F-18 FDG positron emission tomography/computed tomography (PET/CT) one year after the detection of metastatic brain tumor

Oncology Letters

Volumn 2, Issue 4, 2011, Pages 621-623

  Ozeki, Yuichi ^a   Abe, Yoshiyuki ^b   Kita, Hideyuki ^c   Tamura, Katsumi ^b   Sakata, Ikuko ^b   Ishida, Jiro ^b   Machida, Kikuo ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Tokorozawa PET Diagnostic Imaging Clinic   (Japan)

^c Department of Neurosurgery   (Japan)

Author keywords

Lung cancer; Metastatic brain tumor; PET CT; Unknown primary origin

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BRAIN BIOPSY; BRAIN CANCER; CANCER DIAGNOSIS; CANCER OF UNKNOWN PRIMARY SITE; CANCER STAGING; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; HUMAN; LOBECTOMY; LUNG CANCER; LYMPH NODE DISSECTION; MALE; MEDIASTINUM LYMPH NODE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; SURGICAL TECHNIQUE; UNDIFFERENTIATED CARCINOMA;

EID: 79958044973     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.318     Document Type: Article

References (12)

1. Pimiento JM, Teso D, Malkan A, Dudrick SJ and Palesty JA: Cancer of unknown primary origin: a decade of experience in a community-based hospital. Am J Surg 194: 833-838, 2007.
2. Pavlidis N, Briasoulis E, Hainsworth J and Greco FA: Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 39: 1990-2005, 2003.
3. Wu AH, Drees JC, Wang H, VandenBerg SR, Lal A, Henner WD and Pillai R: Gene expression profiles help identify the tissue of origin for metastatic brain cancers. Diagn Pathol 26: 26, 2010.
4. Podoloff DA: PET/CT and occult primary tumors. J Natl Compr Canc Netw 7: 239-244, 2009.
5. Pelosi E, Pennone M, Deandreis D, Douroukas A, Mancini M and Bisi G: Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site. Q J Nucl Med Mol Imaging 50: 15-22, 2006.
6. Ueda S, Tsuda H, Asakawa H, Shigekawa T, Fukatsu K, Kondo N, Yamamoto M, Hama Y, Tamura K, Ishida J, Abe Y and Mochizuki H: Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer. Jpn J Clin Oncol 38: 250-258, 2008.
7. Abe Y, Tamura K, Sakata, I, Ishida J, Mukai M, Ohtaki M, Nakamura M and Machida K: Unique intense uptake demonstrated by 18F-FDG positron emission tomography/computed tomography (PET/CT) in primary pancreatic lymphoma: A case report. Oncol Lett 1: 605-607, 2010.
8. Abe Y, Tamura K, Sakata, I, Ishida J, Fukuba I, Matsuoka R, Shimizu S, Murakami H and Machida K: Usefulness of 18F-FDG positron emission tomography/computed tomography for diagnosis of pyothorax-associated lymphoma: A report of three cases. Oncol Lett 1: 833-836, 2010.
9. Popović N and Kalacun D: Origin and distribution of brain metastases. Med Pregl 57: 617-621, 2004.
10. Hubbs JL, Boyd JA, Hollis D, Chino JP, Saynak M and Kelsey CR: Factors associated with the development of brain metastases: analysis of 975 patients with early stage nonsmall cell lung cancer. Cancer 116: 5038-5046, 2010.
11. Fleming AJ Jr and Johansen ME: The clinician's expectations from the use of positron emission tomography/computed tomography scanning in untreated and treated head and neck cancer patients. Curr Opin Otolaryngol Head Neck Surg 16: 127-134, 2008.
12. Salem S, Patel NH, Barwick T, Al-Nahhas A, Howard DJ, Zerizer I and Win Z. Occult squamous cell carcinoma of the uvula detected by F-18 FDG PET/CT in a case of carcinoma of unknown primary in the head and neck. Clin Nucl Med 35: 800-801, 2010.